Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Should persons with autosomal dominant AD be included in clinical trials?

Grill JD, Ringman JM.

Alzheimers Res Ther. 2011 May 23;3(3):18. doi: 10.1186/alzrt80. No abstract available.

2.

Should persons with autosomal dominant AD be included in clinical trials? Authors' response.

Szigeti K, Doody RS.

Alzheimers Res Ther. 2011 May 23;3(3):19. doi: 10.1186/alzrt81. No abstract available.

3.

Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.

Lleó A, Blesa R, Queralt R, Ezquerra M, Molinuevo JL, Peña-Casanova J, Rojo A, Oliva R.

Arch Neurol. 2002 Nov;59(11):1759-63.

PMID:
12433263
4.

[Diversity in autosomal-dominant diseases in the Russian population].

Zinchenko-Mamedova RA, El'chinova GI, Nurbaev SD, Ginter EK.

Genetika. 2001 Mar;37(3):373-85. Russian.

PMID:
11357371
5.

The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome.

Yanagimachi M, Ohya T, Yokosuka T, Kajiwara R, Tanaka F, Goto H, Takashima T, Morio T, Yokota S.

J Clin Immunol. 2016 Jul;36(5):511-6. doi: 10.1007/s10875-016-0278-1. Epub 2016 Apr 18.

PMID:
27091139
6.

Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses.

Carrozzo R, Hirano M, Fromenty B, Casali C, Santorelli FM, Bonilla E, DiMauro S, Schon EA, Miranda AF.

Neurology. 1998 Jan;50(1):99-106.

PMID:
9443465
7.

Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant.

Thornton PS, Satin-Smith MS, Herold K, Glaser B, Chiu KC, Nestorowicz A, Permutt MA, Baker L, Stanley CA.

J Pediatr. 1998 Jan;132(1):9-14.

PMID:
9469993
8.

Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature.

Silverio A, Prota C, Di Maio M, Polito MV, Cogliani FM, Citro R, Gigantino A, Iesu S, Piscione F.

Nephrology (Carlton). 2015 Apr;20(4):229-35. doi: 10.1111/nep.12373. Review.

PMID:
25476912
9.

The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease.

Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM.

Contemp Clin Trials. 2013 Sep;36(1):256-62. doi: 10.1016/j.cct.2013.07.006. Epub 2013 Jul 19.

10.

Clinical features of autosomal dominant congenital nystagmus linked to chromosome 6p12.

Kerrison JB, Koenekoop RK, Arnould VJ, Zee D, Maumenee IH.

Am J Ophthalmol. 1998 Jan;125(1):64-70.

PMID:
9437315
11.

Prevalence and clinical profile of autosomal dominant type 2 diabetes from a diabetes centre in India.

Mohan V, Pranjali PP, Amutha A, Ganesan A, Datta M, Gayathri P.

Prim Care Diabetes. 2009 Nov;3(4):233-8. doi: 10.1016/j.pcd.2009.09.004. Epub 2009 Nov 4.

PMID:
19892614
12.

The role of noise and positive feedback in the onset of autosomal dominant diseases.

Bosl WJ, Li R.

BMC Syst Biol. 2010 Jun 29;4:93. doi: 10.1186/1752-0509-4-93.

13.

Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease.

Ringman JM, Pope W, Salamon N.

J Neurol. 2010 May;257(5):839-42. doi: 10.1007/s00415-009-5436-4. Epub 2010 Jan 3.

14.

Early onset familial Alzheimer's disease: Mutation frequency in 31 families.

Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J.

Neurology. 2003 Jan 28;60(2):235-9.

PMID:
12552037
15.

[Hereditary nervous system diseases in Mordovia].

Petrin AN, Perepelov AV, Nurbaev SD, Balanovskaia EV, Sitnikov VF, Inozemtseva VS, Rudenskaia GE.

Genetika. 1997 Jun;33(6):836-43. Russian.

PMID:
9289422
16.

Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C.

Hum Mol Genet. 1998 Jan;7(1):43-51.

PMID:
9384602
17.

Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.

Tkachenko O, Helal I, Shchekochikhin D, Schrier RW.

Curr Hypertens Rev. 2013 Feb;9(1):12-20. Review.

PMID:
23971639
18.
19.

A high-throughput resequencing microarray for autosomal dominant spastic paraplegia genes.

Dufke C, Schlipf N, Schüle R, Bonin M, Auer-Grumbach M, Stevanin G, Depienne C, Kassubek J, Klebe S, Klimpe S, Klopstock T, Otto S, Poths S, Seibel A, Stolze H, Gal A, Schöls L, Bauer P.

Neurogenetics. 2012 Aug;13(3):215-27. doi: 10.1007/s10048-012-0329-6. Epub 2012 May 3.

PMID:
22552817
20.

Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.

Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Karttunen N, Pylkkänen L, Tiihonen J, Hartikainen S.

Pain. 2017 Feb;158(2):252-260. doi: 10.1097/j.pain.0000000000000752.

PMID:
28092324

Supplemental Content

Support Center